BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$77.63 USD
-1.20 (-1.52%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $77.61 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 61 - 80 ( 188 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 102122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 101122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 10122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 92122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 91122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 9122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 82122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 81122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
4Q22 - Growth Drivers Offsetting FX Headwinds
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 8122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 72122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 71122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 7122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
2Q Preview - Mapping COVID Sales; 2023 Visibility Increasing
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 62122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 61122
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for TECH 6122
Provider: Stock Traders Daily
Analyst: Research Department